Viatris Q2 earnings on deck: What to expect
I'm PortAI, I can summarize articles.
Pharmaceutical company Viatris (NASDAQ:VTRS) is set to announce its Q2 earnings on Thursday, with Wall Street expecting an EPS of $0.56, a 19% decline, and revenue of $3.46 billion, down 9%. Viatris has beaten EPS and revenue estimates 75% of the time over the past year. The stock has dropped nearly 29% this year, attributed to pipeline setbacks and failed R&D efforts, leading analysts to rate it as a Hold. Recent revisions show mixed changes in EPS and revenue estimates.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments